AGP Picks
View all

Healthy Living Maldives
Provided by AGP

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 4, 2026

Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction
Jun. 4, 2026

Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction

Indeterminate GlobeNewswire
Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service
Jun. 4, 2026

Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service

Indeterminate GlobeNewswire
Orange Plan Management Celebrates 4.9-Star Review Milestone, Reinforcing Its Role as a Leading NDIS Plan Manager in Australia
Jun. 4, 2026

Orange Plan Management Celebrates 4.9-Star Review Milestone, Reinforcing Its Role as a Leading NDIS Plan Manager in Australia

Indeterminate GlobeNewswire
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
Jun. 4, 2026

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Indeterminate GlobeNewswire
DLH Announces Filing of New Shelf Registration Statement
Jun. 4, 2026

DLH Announces Filing of New Shelf Registration Statement

Indeterminate GlobeNewswire
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Jun. 4, 2026

Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium

Indeterminate GlobeNewswire
Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental
Jun. 4, 2026

Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental

Indeterminate GlobeNewswire
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Jun. 4, 2026

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors

Indeterminate GlobeNewswire
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
Jun. 4, 2026

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

Indeterminate GlobeNewswire
TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology
Jun. 4, 2026

TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology

Indeterminate GlobeNewswire
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
Jun. 4, 2026

GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE

Indeterminate GlobeNewswire
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
Jun. 4, 2026

GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN

Indeterminate GlobeNewswire
CooperCompanies Announces Second Quarter 2026 Results
Jun. 4, 2026

CooperCompanies Announces Second Quarter 2026 Results

Indeterminate GlobeNewswire
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 
Jun. 4, 2026

BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 

Indeterminate GlobeNewswire
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Jun. 4, 2026

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

Indeterminate GlobeNewswire
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Jun. 4, 2026

Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Jun. 4, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Jun. 4, 2026

Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress

Indeterminate GlobeNewswire
Nyxoah Announces Proposed Offering of Ordinary Shares
Jun. 4, 2026

Nyxoah Announces Proposed Offering of Ordinary Shares

Indeterminate GlobeNewswire
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
Jun. 4, 2026

Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Healthy Living Maldives

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.